Company Revenue

SeaSpine grew in the high single digits for 3Q21 and continues its investments to drive share gains and growth....

The company grew in the low single digits for 3Q21 and anticipates a gradual recovery from declines brought on by...

The company's orthopedic business grew only 2% organically in 3Q21 due to the Delta variant and hospital staffing shortages....

Direct sales of MagnetOs bone graft in the U.S. continued to grow in 3Q21, with a year-to-date increase of 119%...

The company grew 0.5% in the third quarter of 2021 compared to the year prior as procedure declines peaked in...

The company grew nearly 30% in 1H21 but has not yet achieved volumes seen in 2019. MicroPort did, however, make...

The company declined in the mid-single digits in 1H21 due to market instability caused by China's volume-based procurement policy....

In 2Q21, the company regained much of its pre-pandemic growth momentum except for a lagging recovery in Italy....

The company's FY 1Q22 saw double-digit growth in its spine business, driven by strength in biologics and recovering surgical volumes....

The company grew nearly 30% in the first half of 2021, with important contributions coming from its growing presence in...